Skip to content
1st Counsel – Lifestyle
Author:
F. Hoffman-La Roche AG
/C O R R E C T I O N — Roche/
March 24, 2026
Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE markets
March 24, 2026
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer’s disease
March 16, 2026
New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools
March 5, 2026